6 rezultatima
TECHNICAL FIELD
This invention relates to novel tetrazolyl-substituted quinuclidine compounds and their pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and the use of such compounds as substance P antagonists.
BACKGROUND ART
Substance P is a naturally
TECHNICAL FIELD
This invention relates to substituted 3-[(5-substituted benzyl)amino]-2-phenylpiperidine compounds and their pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and use of such compounds as substance P antagonists.
BACKGROUND ART
Substance P is a
TECHNICAL FILED
This invention relates to substituted benzylaminopiperidine compounds of interest to those in the field of medical chemistry and chemotherapy. More particularly, it is concerned with a series of substituted piperidine compounds, including their pharmaceutically acceptable salts,
TECHNICAL FIELD
This invention relates to novel piperidinylamino tricyclic compounds and their pharmaceutically acceptable salts, and to pharmaceutical compositions containing them. The pharmaceutically active compounds of this invention can be used as substance P antagonists.
BACKGROUND
TECHNICAL FIELD
This invention relates to novel piperidinylamino tricyclic compounds and their pharmaceutically acceptable salts, and to pharmaceutical compositions containing them. The pharmaceutically active compounds of this invention can be used as substance P antagonists.
BACKGROUND
TECHNICAL FIELD
This invention relates to substituted benzylaminopiperidine compounds of interest to those in the field of medical chemistry and chemotherapy. More particularly, it is concerned with a series of substituted piperidine compounds, including their pharmaceutically acceptable salts,